The Thyroid Eye Disease (TED) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Thyroid Eye Disease (TED) Market?
The global market for Thyroid Eye Disease (TED) has been experiencing significant growth recently. The market was valued at $2.15 billion in 2024 and is expected to reach $2.30 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Thyroid Eye Disease (TED) Industry?
The 2029 market projections for the Thyroid Eye Disease (TED) Global Market Report 2025 are forecasted to be $2.97 billion in size, with a compound annual growth rate (CAGR) of 6.6%.
Download Your Free Sample of the 2025 Thyroid Eye Disease (TED) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Thyroid Eye Disease (TED) Market?
The key drivers in the thyroid eye disease (ted) market are:
• Rising prevalence of Graves' disease
• Increase in funding in various industries
• Growing healthcare expenditure
• Increased usage of thyroid hormone replacement therapy
Global Market Segmentation: Identifying Major Thyroid Eye Disease (TED) Industry Segments
The thyroid eye disease (TED) market covered in this report is segmented –
1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical
2) By Disease Severity: Mild, Moderate, Severe
3) By Drug Type: Biologics, Small Molecules, Others Drug Type
4) By Route Of Administration: Oral, Intravenous, Subcutaneous
5) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches
Pre-order the 2025 Thyroid Eye Disease (TED) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Thyroid Eye Disease (TED) Market?
The key trends in the thyroid eye disease (ted) market are:
• Technological advancements are expected to have a significant impact on the TED market.
• There is an emerging trend of expansion in R&D activities within this field.
• The development of novel drugs represents an important trend.
• Advancements in treatment options and new surgical techniques are also emerging trends.
Who Are the Top Competitors & Leading Players in the Thyroid Eye Disease (TED) Market?
Major players in the thyroid eye disease (ted) market are:
• Hoffmann-La Roche AG
• Amgen Inc.
• Genentech Inc.
• Horizon Therapeutics plc
• Pierre Fabre S.A.
• Innovent Biologics Inc.
• ACELYRIN Inc.
• Soleo Health
• Zai Lab Limited
• HanAll Biopharma Co. Ltd.
• Tourmaline Bio Inc.
• Zenas BioPharma Inc.
• Immunovant Inc.
• Verana Health
• Harbour BioMed (Guangzhou) Co. Ltd.
• Sling Therapeutics Inc.
• Crinetics Pharmaceuticals Inc.
• Lassen Therapeutics Inc.
• Viridian Therapeutics Inc.
• Minghui Pharmaceutical Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the thyroid eye disease (TED) market in 2024
